行情

HTGM

HTGM

HTG Molecular
NASDAQ

实时行情|Nasdaq Last Sale

0.6993
+0.0249
+3.69%
已收盘, 16:00 11/18 EST
开盘
0.6750
昨收
0.6744
最高
0.7095
最低
0.6700
成交量
49.13万
成交额
--
52周最高
3.680
52周最低
0.6000
市值
4,058.12万
市盈率(TTM)
-1.2038
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

HTGM 新闻

  • Health Check: How Prudently Does HTG Molecular Diagnostics (NASDAQ:HTGM) Use Debt?
  • Simply Wall St..4天前
  • The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
  • Benzinga.5天前
  • HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.6天前
  • HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Lags Revenue Estimates
  • Zacks.6天前

更多

所属板块

先进医疗设备和技术
-0.99%
医疗设备和用品
-0.74%

热门股票

名称
价格
涨跌幅

HTGM 简况

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
展开

Webull提供HTG Molecular Diagnostics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。